After successful the Nobel Prize in Drugs in 2009, Dr. Elizabeth Blackburn Started the organization in 2010, basing its business model on her award-profitable premise. She postulated that telomeres execute a important part within the defense of our genetic signature and that we should always do everything in our electrical power to delay their shor